Evidence map›Paper›PMID 34287099›Full record

ArticleCell cycle (Georgetown, Tex.)2021

MiR-532-3p suppresses cell viability, migration and invasion of clear cell renal cell carcinoma through targeting TROAP.

Bin Gao, Lijuan Wang, Yubo Zhang, Na Zhang, Miaomiao Han, Huancai Liu, Dongli Sun, Yifei Liu

Open access · bronzeAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Life science alliance · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bin GaoDepartment of Urology, Tangshan Central Hospital, Tangshan, Hebei, P.R. China.
Lijuan WangDepartment of Urology, Tangshan Central Hospital, Tangshan, Hebei, P.R. China.
Yubo ZhangDepartment of Urology, Tangshan Central Hospital, Tangshan, Hebei, P.R. China.
Na ZhangDepartment of Urology, Tangshan Central Hospital, Tangshan, Hebei, P.R. China.
Miaomiao HanDepartment of Urology, Tangshan Central Hospital, Tangshan, Hebei, P.R. China.
Huancai LiuDepartment of Urology, Tangshan Central Hospital, Tangshan, Hebei, P.R. China.
Dongli SunDepartment of Urology, Tangshan Central Hospital, Tangshan, Hebei, P.R. China.
Yifei LiuDepartment of Urology, Tangshan Central Hospital, Tangshan, Hebei, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear cell renal cell carcinoma (ccRCC) is a subtype of renal cell cancer with the highest mortality, infiltration, and metastasis rate, threatening human health. Despite oncogenic role of TROAP in various cancers, its function in ccRCC remains to be unraveled. The differentially expressed mRNAs (DEmRNAs) and miRNAs (DEmiRNAs) were obtained by analyzing the related data sets of ccRCC in TCGA. The expression levels of mRNAs and miRNAs in the cell were detected by qRT-PCR, while the protein levels were characterized by western blot. The viability, migratory and invasive abilities of ccRCC cells were determined by MTT, wound healing and cell invasion assays. The combination of miRNA target site prediction and dual-luciferase reporter gene assay verified the binding relationship between miR-532-3p and TROAP. Research on ccRCC displayed that TROAP expression was upregulated, while miR-532-3p was down-regulated. Besides, upregulation of TROAP could accelerate viability, migratory and invasive potentials of ccRCC cells. On the contrary, miR-532-3p could downregulate TROAP level, but TROAP upregulation reversed the viability, migration, and invasion of ccRCC cells. MiR-532-3p could attenuate the viability, migration and invasion of ccRCC cells by targeting TROAP. This may generate novel insights into molecular therapeutic targets for ccRCC.

Indexed as

Cell MovementCarcinoma, Renal CellCell Adhesion MoleculesCell Line, TumorCell SurvivalGene Expression Regulation, NeoplasticHumansKidney NeoplasmsMicroRNAsNeoplasm InvasivenessSignal TransductionCell Adhesion MoleculesMicroRNAsMIRN532 microRNA, humanTROAP protein, humancell viabilityClear cell renal cell carcinomainvasionmigrationmiR-532-3pTROAP

Identifiers

PMID34287099
PMCPMC8409774
OpenAlexW3183542265

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.